Literature DB >> 3080012

Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.

C Blomström-Lundqvist, M Dohnal, I Hirsch, A Lindblad, A Hjalmarson, S B Olsson, N Edvardsson.   

Abstract

The effects of long term (4 weeks) treatment with oral metoprolol (100 mg twice daily) and sotalol (160 mg twice daily) on ventricular repolarisation time were compared in a double blind crossover study in 20 patients post-infarction. For QT interval studies transoesophageal atrial pacing was performed at a cycle length of 800 ms. Sotalol prolonged the QT interval by 5-7% compared with metoprolol. The prolongation reflects a change in the repolarisation time because there was no change in the QS interval. Measurements of heart rate at rest and during bicycle exercise indicated that metoprolol and sotalol in the doses selected were equipotent as beta blockers. Transoesophageal atrial pacing is a simple non-invasive method with few and mild side effects that is well suited to drug studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080012      PMCID: PMC1232115          DOI: 10.1136/hrt.55.2.181

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

Review 1.  A survey of the pharmacological properties of metoprolol in animals and man.

Authors:  B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits.

Authors:  E M Williams; A E Raine; A A Cabrera; J M Whyte
Journal:  Cardiovasc Res       Date:  1975-09       Impact factor: 10.787

Review 3.  The use of beta adrenergic blocking drugs in cardiovascular disease.

Authors:  B N Prichard
Journal:  Scott Med J       Date:  1976-10       Impact factor: 0.729

4.  Use of the pill electrode for transesophageal atrial pacing.

Authors:  J M Jenkins; M Dick; S Collins; W O'Neill; R M Campbell; D J Wilber
Journal:  Pacing Clin Electrophysiol       Date:  1985-07       Impact factor: 1.976

5.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

Review 6.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Effect of intravenous propranolol on QT interval. A new method of assessment.

Authors:  J R Milne; A J Camm; D E Ward; R A Spurrell
Journal:  Br Heart J       Date:  1980-01

8.  Beta blocking drugs as anti-arrhythmic agents.

Authors:  J D Fitzgerald
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-04

9.  Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation.

Authors:  A E Raine; E M Vaughan Williams
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

10.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

View more
  3 in total

Review 1.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.

Authors:  K Hirao; K Okishige; F Suzuki; K Hiejima
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 3.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.